AIM Vaccine Balance Sheet Health
Financial Health criteria checks 3/6
AIM Vaccine has a total shareholder equity of CN¥3.9B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 45.3%. Its total assets and total liabilities are CN¥7.3B and CN¥3.4B respectively.
Key information
45.3%
Debt to equity ratio
CN¥1.76b
Debt
Interest coverage ratio | n/a |
Cash | CN¥736.42m |
Equity | CN¥3.89b |
Total liabilities | CN¥3.37b |
Total assets | CN¥7.26b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6660's short term assets (CN¥2.5B) do not cover its short term liabilities (CN¥2.6B).
Long Term Liabilities: 6660's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥770.5M).
Debt to Equity History and Analysis
Debt Level: 6660's net debt to equity ratio (26.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 6660's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6660 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6660 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.2% each year